MD Anderson Automates Laboratory Workflow with Stone Bond Technologies' EE-LIMS™
News Jul 03, 2008
The newly established Small Interfering Ribonucleic Acid (siRNA) Facility at M. D. Anderson Cancer Center has been charged with providing high quality siRNA screening services for both internal and external customers.
M. D. Anderson has chosen Stone Bond Technologies’ EE-LIMS™ to document activities within the laboratory workflow at its siRNA facility, increasing throughput, while reducing the risk of errors, and providing automation for the management of operations in its siRNA Laboratory.
As one of the newest fields in the study of nucleic acids, small interfering RNA has shown considerable potential in laboratory studies to change how diseases are treated. Considering how difficult it is to work with these molecules and the specialized equipment devoted to their isolation and study, labs specializing in this area have a strong need to document the work that goes into producing genetic data that corresponds to the RNA in a given sample.
According to Stone Bond, its LIMS is an award winning Web-based laboratory information management system, recipient of the Bio-IT World magazine’s Grand Prize winner for technical innovation in its annual Best Practice awards, in the category of IT Infrastructure and Informatics.
Built on Stone Bond’s versatile Enterprise Enabler integration platform, EE-LIMS automates laboratory workflows, invoicing, data and sample tracking, collections and other business processes to help laboratories reduce overhead and administrative costs.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Evidence of Drinking Water Contamination from FrackingNews
A study of drinking water in Appalachian Ohio found no evidence of natural gas contamination from recent oil and gas drilling.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018